Capricor Therapeutics ($CAPR) Insider Trading & Smart Money Activity
Capricor Therapeutics, Inc. ($CAPR) has 9 insider trades and 2 13F position changes on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($24K), net -$24K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$24K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 0
CAPR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $24K | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CAPR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Karen KrasneyEVP, GENERAL COUNSEL | Sell (Option exercise) | 24.10K sh | -23.7% | -77.0% | Read | |||||
| Insider | Anthony BergmannCHIEF FINANCIAL OFFICER | Sell (Option exercise) | 24.10K sh | -23.7% | -77.0% | Read | |||||
| Insider | Anthony BergmannCHIEF FINANCIAL OFFICER | Buy (Option exercise) | 24.10K sh | $76.64K | -23.7% | -77.0% | Read | ||||
| Insider | Karen KrasneyEVP, GENERAL COUNSEL | Sell (Open-market sale) | 400 sh | $12K | -21.8% | -33.2% | Read | ||||
| Insider | Karen KrasneyEVP, GENERAL COUNSEL | Buy (Option exercise) | 400 sh | $1.27K | -21.8% | -33.2% | Read | ||||
| Insider | Anthony BergmannCHIEF FINANCIAL OFFICER | Sell (Open-market sale) | 400 sh | $12K | -21.8% | -33.2% | Read | ||||
| Insider | Anthony BergmannCHIEF FINANCIAL OFFICER | Buy (Option exercise) | 400 sh | $1.27K | -21.8% | -33.2% | Read | ||||
| Insider | Karen KrasneyEVP, GENERAL COUNSEL | Sell (Option exercise) | 500 sh | -18.9% | -35.5% | Read | |||||
| Insider | Anthony BergmannCHIEF FINANCIAL OFFICER | Sell (Option exercise) | 500 sh | -18.9% | -35.5% | Read | |||||
| 13F | Mercer Global Advisors | New | +403K sh | $9.70M | +0.3% | -7.2% | — | ||||
| 13F | Mercer Global Advisors | New | +403K sh | $10.40M | +0.3% | -7.2% | — |
1W / 1M / 6M = how CAPR moved from the trade or filing date.
Insider trading in CAPR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Anthony Bergmann | CHIEF FINANCIAL OFFICER | 5 | -$12K | Jun 25, 2026 | |
| Karen Krasney | EVP, GENERAL COUNSEL | 4 | -$12K | Jun 25, 2026 |
Institutions moving CAPR (13F)
Frequently asked questions
Are CAPR insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $24K, a net -$24K.
What is the latest insider trade in CAPR?
Karen Krasney, EVP, GENERAL COUNSEL filed a sell (option exercise) of 24.10K sh on Jun 25, 2026.
Which institutions changed their CAPR positions?
Recent 13F filers moving the stock include Mercer Global Advisors.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.